Narrow-band ultraiolet B monotherapy plus calcipotriol in the treatment of vulgaris psoriasis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001654

Enrollment

Unknown

Registered

2011-10-21

Start date

2011-10-21

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

B:phototherapy

A:Narrow-band ultraiolet B monotherapy plus calcipotriol

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. 18-65 years old.vulgaris psoriasis; 2. 5-30% body surface area involvement.

Exclusion criteria

Exclusion criteria: 1. other subtype of psoriasis; 2. more than 30% body surface area involvement.

Design outcomes

Primary

Measure	Time frame
PAS;	—

Countries

China

Contacts

Public ContactGang Wang

xjwgang@fmmu.edu.cn+86 29 84775406

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026